Redwood Pharma AB (publ)

At a glance

Most recent filing on November 16, 2021 — an open-market purchase by Martin Olov Vidaeus on Nov 16, 2021.

We hold 5 visible filings, going back to March 18, 2020.

Filings we could not classify with confidence are set aside for review, so they are in none of these counts.

Insider trades

All 5 shown

This page is free to read, and it stops after 5 rows. Everything we currently hold fits inside that, so nothing is being held back here today. Reading the whole list, and the full version of the page each row opens (that page itself opens free, with its first rows), is part of the subscription. So are the price history with every buy marked, the price change beside each line, and any moments with several buyers or buying streaks. What that costs is on the pricing page. Already subscribed? Sign in and this page opens in full.

Martin Olov Vidaeus Chief executive officer
26,000 SEKOpen-market buy
TradedNov 16, 2021FiledNov 16, 2021
Martin Olov Vidaeus Chief executive officer
16,980 SEKOpen-market buy
TradedJul 19, 2021FiledJul 19, 2021
Martin Olov Vidaeus Chief executive officer
28,140 SEKOpen-market buy
TradedOct 10, 2020FiledOct 10, 2020
Martin Olov Vidaeus Chief executive officer
20,560 SEKOpen-market buy
TradedMar 18, 2020FiledMar 18, 2020
Gunnar Mattsson Board member or deputy board member
45,850 SEKOpen-market buy
TradedMar 18, 2020FiledMar 18, 2020